APA (7th ed.) Citation

Ferro, M., Tătaru, O. S., Musi, G., Lucarelli, G., Abu Farhan, A. R., Cantiello, F., . . . Autorino, R. (2022). Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette–Guerin Immunotherapy. Diagnostics (2075-4418), 12(3), 586. https://doi.org/10.3390/diagnostics12030586

Chicago Style (17th ed.) Citation

Ferro, Matteo, et al. "Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette–Guerin Immunotherapy." Diagnostics (2075-4418) 12, no. 3 (2022): 586. https://doi.org/10.3390/diagnostics12030586.

MLA (9th ed.) Citation

Ferro, Matteo, et al. "Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette–Guerin Immunotherapy." Diagnostics (2075-4418), vol. 12, no. 3, 2022, p. 586, https://doi.org/10.3390/diagnostics12030586.